|
PACSIN2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.67079741340149E-11 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.56330000056215E-08 |
| Normal-vs-Stage2 |
6.20949999999842E-05 |
| Normal-vs-Stage3 |
8.93120022382732E-11 |
| Normal-vs-Stage4 |
9.53199741360322E-11 |
| Stage1-vs-Stage2 |
6.483800E-01 |
| Stage1-vs-Stage3 |
9.604500E-02 |
| Stage1-vs-Stage4 |
2.926300E-02 |
| Stage2-vs-Stage3 |
1.128620E-01 |
| Stage2-vs-Stage4 |
3.209700E-02 |
| Stage3-vs-Stage4 |
3.638200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.66107185970577E-12 |
| Normal-vs-AfricanAmerican |
9.56939999999795E-05 |
| Normal-vs-Asian |
2.07749999999729E-05 |
| Caucasian-vs-AfricanAmerican |
7.047800E-01 |
| Caucasian-vs-Asian |
6.072400E-01 |
| AfricanAmerican-vs-Asian |
9.890800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.91910000008266E-08 |
| Normal-vs-Female |
7.67199637152771E-11 |
| Male-vs-Female |
9.724400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.77070000065783E-08 |
| Normal-vs-Age(41-60Yrs) |
2.23689955447526E-10 |
| Normal-vs-Age(61-80Yrs) |
1.43519973683226E-10 |
| Normal-vs-Age(81-100Yrs) |
1.600800E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.543400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.105250E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.115400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.655400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.528200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.300000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.815280E-03 |
| Classical-VS-Follicular |
2.515400E-01 |
| Classical-VS-Other |
2.306600E-01 |
| Classical-VS-Normal |
5.10050002233697E-09 |
| Tall-VS-Follicular |
1.430410E-01 |
| Tall-VS-Other |
9.693000E-01 |
| Tall-VS-Normal |
3.55520057837566E-11 |
| Follicular-VS-Other |
5.509200E-01 |
| Follicular-VS-Normal |
5.88820000535506E-08 |
| Other-VS-Normal |
8.556200E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.78670009079951E-10 |
| Normal-vs-N1 |
2.88790003022399E-09 |
| N0-vs-N1 |
1.430200E-01 |
|
|
